Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

64.13%

67.75%

64.90%

Annual Dental Visits (ADV) Total

NB

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

32.40%

29.97%

46.74%

Appropriate Testing for Pharyngitis (CWP)

71.59%

78.18%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI)

88.16%

88.19%

93.08%

Asthma Medication Ratio (AMR) Total

63.15%

61.81%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

50.11%

58.62%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

64.72%

59.37%

68.61%

Breast Cancer Screening (BCS)

53.25%

53.52%

55.25%

Cervical Cancer Screening (CCS)

62.53%

56.20%

59.85%

Childhood Immunization Status (CIS) Combination #10

25.79%

19.95%

35.04%

Chlamydia Screening in Women (CHL) Total

57.78%

58.78%

61.07%

Controlling High Blood Pressure (CBP)

54.74%

55.47%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

79.97%

80.72%

80.86%

Eye Exam for Patients With Diabetes (EED)

56.45%

53.04%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

11.23%

20.12%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

42.06%

42.42%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

37.88%

32.38%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

25.19%

28.98%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

45.50%

62.65%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

46.23%

51.82%

55.72%

Immunizations for Adolescents (IMA) Combination #2

28.95%

32.36%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Rate Total

11.92%

11.51%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

25.66%

28.57%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

26.94%

28.37%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

52.43%

33.78%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

68.87%

73.67%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

79.47%

81.43%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

89.25%

94.30

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

87.83%

84.91%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

75.67%

77.86%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

13.89%

13.38%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

2.83%

2.80%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

82.32%

82.72%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

59.68%

64.40%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

66.58%

66.45%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

55.51%

56.96%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

54.50%

57.00%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

68.69%

66.81%

75.44%

Use of Opioids at High Dosage (HDO)

1.93%

3.74%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

1.16%

0.98%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

70.56%

70.07%

83.21%